These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32065670)

  • 1. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
    Sonigo C; Bajeux J; Boubaya M; Eustache F; Sifer C; Lévy V; Grynberg M; Sermondade N
    Hematol Oncol; 2020 Oct; 38(4):560-564. PubMed ID: 32065670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
    Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
    Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
    Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
    Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
    Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
    Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro maturation of immature oocytes from ovarian tissue prior to shipment to a cryobank.
    Dietrich JE; Jauckus J; Hoffmann S; Liebenthron J; Capp E; Strowitzki T; Germeyer A
    Arch Gynecol Obstet; 2020 Oct; 302(4):1019-1024. PubMed ID: 32556511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
    Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
    J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro maturation of germinal vesicle and metaphase I eggs prior to cryopreservation optimizes reproductive potential in patients undergoing fertility preservation.
    Lee JA; Sekhon L; Grunfeld L; Copperman AB
    Curr Opin Obstet Gynecol; 2014 Jun; 26(3):168-73. PubMed ID: 24752002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro maturation of oocytes recovered during cryopreservation of pre-pubertal girls undergoing fertility preservation.
    Fouks Y; Hamilton E; Cohen Y; Hasson J; Kalma Y; Azem F
    Reprod Biomed Online; 2020 Nov; 41(5):869-873. PubMed ID: 32843309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
    Gayete-Lafuente S; Turan V; Oktay KH
    J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation.
    Kedem A; Yerushalmi GM; Brengauz M; Raanani H; Orvieto R; Hourvitz A; Meirow D
    J Assist Reprod Genet; 2018 May; 35(5):851-856. PubMed ID: 29574609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in female patients with hematological disorders.
    Wu D; Shen H
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):61. PubMed ID: 35065646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
    Creux H; Monnier P; Son WY; Buckett W
    J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.